Real-world analysis shows limited spirometry and DLCO effectiveness for ILD screening in rheumatoid arthritis, suggesting an integrated approach.
In this real-world RA cohort, spirometry/DLCO showed limited ability to discriminate hrCT-confirmed ILD once patients were clinically selected for imaging. These findings support an integrated screening strategy in which PFT results are interpreted alongside clinical and radiographic risk factors to guide hrCT referral rather than used as standalone screening tools.
No takes yet. Share an insight, caveat, or question.
Dinache et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: